Are you an expert in pharmacokinetics with a passion for driving innovation in drug development? RBW are partnered with a clinical stage biotech as they're looking for a Head of Pharmacokinetics to lead and shape their DMPK and ADME-Tox strategies across preclinical and clinical development.
This is a unique opportunity to lead a critical function in drug development, influence strategy, and work on innovative projects that make a real impact.
You’ll collaborate with cross-functional teams and contribute to shaping the future of the pipeline.
This will be responsible oversee all pharmacokinetic activities, including bioanalysis, PK/PD, population PK, and PBPK modelling, while ensuring scientific excellence and regulatory compliance.
You’ll manage external vendors, contribute to project strategies, and play a key role in designing Phase I trials and non-clinical studies.
Key Responsibilities:
Lead and coordinate DMPK and ADME-Tox studies for development projects.
Design Phase I clinical trials and contribute to other study designs.
Oversee CRO/vendor selection and ensure quality delivery.
Drive modelling activities (popPK and PBPK).
Provide scientific input for regulatory documents and publications.
Build and maintain a network of experts and foster innovation within the team.
Requirements:
Ph.D specialized training in pharmacokinetics.
5 years’ experience in a pharmaceutical company or CRO.
Expertise in pharmacokinetics, metabolism, and modelling approaches.
Strong knowledge of clinical trial regulations, GLP/GCP, and ICH guidelines.
Proven leadership, project management, and communication skills.
